This brief review summarizes the recently obtained evidence which illustrates the beneficial effects of the endogenously produced antioxidant, melatonin, in reducing tissue damage and reversing cardiac pathophysiology in models of experimental ischemia / reperfusion. The report also describes the actions of other antioxidants, especially vitamin E and antioxidative enzymes, in altering the degree of ischemia / reperfusion damage in the heart. Based on the data available, melatonin seems to have advantages over other antioxidants tested in terms of ameliorating the hypoxia and reoxygenation-induced damage. While the bulk of the studies that have used melatonin to overcome cardiac injury following transient arterial occlusion and subsequent reperfusion have used pharmacological doses to achieve protection, two recent reports have further shown that merely reducing endogenous circulating concentrations of melatonin (by surgical removal of a source of melatonin, i.e. the pineal gland) exaggerates the degree of injury and reduces survival of animals as a result of induced ischemia / reperfusion of the heart. These findings are consistent with observations in other organs where the loss of physiological concentrations of melatonin results in increased oxidative damage during hypoxia and reoxygenation. These findings have implications for the elderly since in the aged endogenous levels of melatonin are naturally reduced thereby possibly predisposing them to more severe cardiac damage during a heart attack. To date, the bulk of the studies relating to the protective actions of melatonin in reducing cardiac ischemia / reperfusion injury have used the rat as the experimental model. Considering the high efficacy of melatonin in limiting ischemia / reperfusion damage as well as melatonin's low toxicity, the studies should be expanded to include other species and models of cardiac ischemia / reperfusion. The results of these investigations would help to clarify the potential importance of the use of melatonin in situations of oxidative damage to the heart in humans.
. Introduction
financial burden on the health care system and on many families. Ischemic heart disease is particularly debilitating In the United States and other economically well-dewith an estimated 1.5 million myocardial infarctions being veloped countries of the world, cardiovascular disease is a reported annually in the US resulting in roughly 200 000 major cause of disability and mortality [1] . In these deaths. Unfortunately, significant reductions in these numcountries, conditions relating to the heart and adnexa bers seem unlikely considering the health status of many account for almost half the deaths that occur each year.
individuals. The American Heart Association estimates up Furthermore, the costs of cardiovascular-related treatments to 50% of US inhabitants have elevated serum cholesterol including emergency room visits, by-pass surgery, cardiac with associated coronary artery disease [2] and in excess of catheterizations and stent placements have placed a major 50% of the population is over weight, a factor that taxes the heart excessively. A reduction in coronary blood flow due to atheros-clerotic plaques or vasospasm can be sufficiently pronumerous and complex reactions in tissues ( Fig. 1 ) which longed to result in severe damage to the myocardium culminate in the mutilation of essential molecules and which leads to cellular injury and eventually to cellular organelles in a number of cells including components of death due to apoptosis and / or necrosis. Loss of this vital the coronary endothelium and myocardium with the retissue ultimately leads to compromised cardiac function cruitment of circulating blood elements, e.g. leukocytes thereby jeopardizing the overall health of the individual and platelets. During the transient ischemia and the period and possibly leading to death. A number of treatment of reperfusion many cells generate by-products of oxygen options have been exploited to reduce cardiac damage that are toxic to the heart. Indeed, the partially reducedresulting from an ischemic episode. Some of these include oxygen metabolites, referred to as reactive oxygen species the use of thrombolytic agents (e.g. tissue plasminogen (ROS) are accepted as accounting for much of the cardiac activator and streptokinase) to dissolve clots and percutadamage that occurs during I / R injury [9, 10] . neous transluminal balloon angioplasty; these procedures are essential to prevent long-term deprivation of oxygenated blood to the heart which would lead to tissue loss; 2 . Use of melatonin to reduce cardiac I / R damage however, the re-instatement of blood flow, i.e. reperfusion, is not without significant negative consequences and Several recent publications present evidence that a cellular damage [3, 4] . Thus, when oxygenated blood renewly discovered antioxidant, melatonin, has significant enters previously hypoxic cardiac tissue it initiates a protective actions against the cardiac damage and altered cascade of events that, paradoxically, results in further physiology that occurs during I / R injury. These actions cellular and tissue damage [5] [6] [7] [8] . This tissue destruction is were apparent even when melatonin was given as a single referred to as reperfusion injury.
acute dose. In light of the observations that melatonin The combination of ischemia / reperfusion (I / R) causes reduced molecular damage and cellular loss in other organs Fig. 1 . As illustrated in this simplified figure, the events that lead to molecular damage and cell death during I / R injury are extremely complex. These processes clearly include free radical generation and ancillary events which eventually cause damage to key macromolecules. Considering the numerous intracellular actions of melatonin as a direct free radical scavenger, as an indirect antioxidant due to its ability to stimulate antioxidative enzymes, and its effect on mitochondrial electron transport and oxidative phosphorylation, this indole has proven effective in reducing molecular damage and cell death in models of rat I / R injury. during transient interruption of blood flow followed by with melatonin (1 or 10 mg / kg i.p.) or 5-MCA-NAT (10 reperfusion, Tan et al. [11] examined its effect on these mg / kg i.p.) 30 min before the hearts were perfused using responses at the level of the heart. Using a Langendorff rat the Langendorff method. In terms of both the physiological heart preparation, a ligature was placed around the deparameters and infarct size, the authors reported that scending coronary artery for 10 min; this was estimated to melatonin or 5-MCA-NAT provided 'spectacular protechave reduced total coronary flow by in excess of 25%. The tion' against I / R injuries. Considering the large amount of ischemic episode was followed by a 10 min reperfusion experimental evidence implicating free radicals in cardiac period during which most hearts (80 and 90%, respectivearrhythmias during hypoxia / reoxygenation [14] , Lagneux ly) exhibited premature ventricular contractions (PVC) et al. [13] surmised that melatonin's free radical scavengand / or ventricular fibrillation (VF). When melatonin was ing activity accounted for its ability to restore cardiac infused throughout the period of the occlusion and after function. However, since the role of free radicals in reopening of the coronary artery, it highly significantly determining infarct size is somewhat less clear [15] , the reduced both the PVC and VF. The arrhythmias in this authors were more cautious in assuming that the reduction study were defined in accordance with the guidelines of the in the size of the lesion was exclusively related to the Lamberth Conventions. The concentration of melatonin in indole's antioxidant properties. the perfusate was either 1, 10 or 50 mM. Anticipating that Additional confirmations of the ameliorative effects of melatonin's effects in this study were likely related to its melatonin on abnormal function and cardiac tissue destrucantioxidant action, as a positive control Tan et al. [11] tion after I / R have been provided by Szarszoi et al. [16] , infused another free radical scavenger, i.e. vitamin C, in a Lee et al. [17] and Sahna and co-workers [18, 19] . In the separate group of hearts. At a concentration of 500 mM first of these reports, melatonin given in pharmacological (i.e. up to 500 times the concentration of melatonin), doses (as in the studies reported above) prior to ischemia ascorbate was significantly less effective than melatonin in and / or during reperfusion reduced the incidence of repreventing the cardiac arrhythmias in this model of I / R. perfusion-induced ventricular fibrillation and decreased the Additional investigations confirming the beneficial efarrhythmia score [16] . This protective action of melatonin fects of melatonin on the physiology and morphology of was presumed to be related to its free radical scavenging the hypoxic / reoxygenated heart followed shortly. Kaneko activity. et al. [12] also used isolated rat hearts that were subjected Lee et al. [17] performed the first in vivo study in which to 30 min ischemia and 30 min perfusion. The conmelatonin was tested for its ability to protect the heart centration of melatonin in the perfusion medium in this when its blood supply is transiently interrupted. Using a study was 100 mM. Again, the duration of ventricular bolus i.v. injection of either 0.5, 1.0 or 5.0 mg / kg before tachycardia and VF were significantly reduced by left coronary artery occlusion, melatonin markedly supmelatonin relative to the durations of these arrhythmias in pressed ventricular tachycardia and fibrillation and also control hearts. Additionally, melatonin significantly rereduced the total number of PVCs (Fig. 2) . Additional stored the function of the left ventricule (LV), i.e. the LV studies showed that melatonin also significantly reduced eight of nine rats with an ischemic / reperfused heart died, [12] further extended their studies by measuring ?OH none of the animals (10 of 10) treated with either 1 or 5 generation (by estimating levels of 2,3-dihydroxybenzoic mg / kg melatonin succumbed. The authors of this report acid after salicylate administration) and observed describe the actions of melatonin as being 'pronounced' melatonin highly significantly reduced the amount of this and presumed its beneficial actions related to both its metabolite in the perfusate. At the conclusion of the ability to reduce neutrophil infiltration into the ischemic / reperfusion period, the hearts were collected and the levels reperfused tissue and due to the antioxidant properties of of lipid peroxidation products were measured in the the indole. tissues. For this endpoint, melatonin again highly sigHeretofore, the studies documenting the protective role nificantly reduced the levels of oxidized lipids in the heart. of melatonin in the hypoxic / reperfused heart used pharmaThese findings clearly documented the beneficial effects of cological doses of the indole. Sahna and co-workers melatonin when it is used during I / R of the heart and the [18, 19] were the first to examine whether endogenous, results are consistent with melatonin's protective actions as physiological concentrations of melatonin would change a free radical scavenger.
the outcome of such studies. In this case, rats were Essentially simultaneously, Lagneux et al. [13] pubsurgically pinealectomized to reduce endogenous levels of lished their findings in which both melatonin and an melatonin and, 2 months later, they, along with pinealanalogue, 5-methoxy-carbonylamino-N-acetyl tryptamine intact controls, were used in studies of cardiac I / R injury. (5-MCA-NAT), were compared in terms of their efficacies When the left coronary artery was occluded for 7 min in reducing both the abnormal cardiac physiology and followed by 7 min of reperfusion, the degree of cardiac infarct volume after I / R. In this case, rats were treated arrhythmias was significantly greater in the heart of the pinealectomized rats compared to the controls. Even more significantly lower than in young individuals [20] . The importantly, the incidence of mortality was 63% in rats findings illustrating a potential role for physiological levels lacking their pineal gland compared to only 25% in the of melatonin in abating cardiac damage during I / R also is pineal-intact rats after I / R induction. These findings interesting in light of several studies showing that humans suggest that endogenous melatonin levels are protective of with cardiovascular disease have noticeably lower circulatthe heart during episodes of hypoxia and reoxygenation. A ing melatonin levels [21] [22] [23] [24] than do age-matched subjects follow-up study by the same group [56] showed that without significant cardiovascular deterioration. Similarly, infarct size was also exaggerated in the ischemia-reperpatients suffering with cardiac syndrome X have an fused heart when rats were deficient in physiological levels attenuated nocturnal rise in serum melatonin levels relative of melatonin due to pinealectomy. This is consistent with to that of age-matched individuals with no cardiac patholpreviously published findings in reference to the brain ogy [25] . It remains unknown, however, whether the where a reduction in endogenous melatonin levels, due to reduced endogenous melatonin levels in patients with pinealectomy, also exaggerated neural injury after an cardiovascular disease is a cause, an effect or even related episode of I / R.
to the compromised cardiovascular function. The results showing increased I / R-induced cardiac All of the studies summarized above in which damage after a reduction in physiological levels of melatonin, either physiologically or pharmacologically, melatonin have implications for the elderly inasmuch as in was found to be protective of both the function and old individuals endogenous levels of melatonin may be morphology of the I / R heart used the rat as the experimen-tal model. The only other species that has been tested in the cardiomyocytes. The reports that have investigated the similar studies is the rabbit. In this report [26] , rabbits efficacy of melatonin as a cardiac protector during I / R underwent coronary artery occlusion and reperfusion and, injury are summarized in Table 1 . when melatonin was given at a dose of either 10 or 50
To further emphasize the efficacy of melatonin in mg / kg i.v., it did not change the hemodynamic parameters reducing I / R damage, the reader is reminded that not only of the I / R heart nor did it alter infarct volume. Melatonin in the heart, but in other organs as well, melatonin has a also did not aggravate any of the parameters tested and the highly favorable effect in reducing tissue damage that authors concluded that it was a safe drug with no apparent follows transient episodes of hypoxia and reoxygenation. side effects on the cardiovascular system. Considering the Thus, in the in vivo brain (including the spinal cord) numerous reports documenting the high efficacy of [29] [30] [31] [32] , liver [33] , kidney [34] , gastrointestinal tract [35] , melatonin in reducing abnormal cardiac physiology, infarct lung [36] and placenta [37] the amount of tissue damage volume and mortality in rats subjected to cardiac I / R, the and the severity of compromised function after I / R were results obtained in this rabbit study would seem to be shown to be reduced when melatonin was employed as an unusual. In evaluating this study, Duncker and Verdouw ameliorative agent. Furthermore, the damage inflicted by [27] point out that the rabbit heart lacks xanthine oxidase other agents that induce high oxidative stress is reduced which may account for the failure of the antioxidant when melatonin is exogenously administered [38] [39] [40] [41] . melatonin to reduce cardiac malfunction during I / R in this Subsequent to the publication of the reports illustrating species. It would seem judicious that melatonin administrathe potential utility of melatonin in the treatment of I / R, tion be reassessed in the rabbit I / R model and certainly in Duncker and Verdouw [27] posed the question as to other species that are considered surrogates for human whether melatonin has a future as a cardioprotective agent. heart attack. This seems especially important given
The authors of the current review feel that this is a melatonin's highly protective effects in models of cardiac reasonable likelihood, not only in terms of protecting I / R in the rat.
against I / R injury but also against cardiotoxicity induced The doses of melatonin used in the aforementioned by a variety of drugs [42] . For example, there is a studies certainly caused blood concentrations of the indole significant amount of literature regarding the beneficial to exceed the physiological levels that normally occur in actions of melatonin at the level of heart in animals treated the species used; therefore, the doses used were unqueswith chemotherapeutic drugs which often have significant tionably pharmacological. On the other hand, pharmacotoxicity in cardiac tissue which results in serious carlogical doses of any effective antioxidant would have to be diomyopathy often leading to congestive heart failure [42-given to reduce the massive cardiac damage that occurs 45]. during ischemia / reperfusion injury. Indeed, the reason the The data that have accumulated to date surely justify oxidative damage occurs in these situations is that the more extensive studies using melatonin in other models physiological levels of all antioxidants combined, i.e.
(and species) of cardiac I / R injury and, if successful, tests glutathione, vitamins C and E, uric acid, etc., are inin humans as well. Melatonin is an uncommonly safe, sufficient to prevent the tissue destruction associated with stable and inexpensive molecule. For example, numerous such an extreme oxidative stress. studies have shown that melatonin, given to humans in A thorough in vitro analysis of melatonin's actions at huge pharmacological doses, e.g. 1 g daily for a month the level of the hypoxic / reoxygenated cardiomyocytes has [46] or in smaller amounts for varying treatment periods been performed by Salie et al. [28] . For this study, adult rat [47] [48] [49] [50] , are without measurable side effects. The same cardiomyocytes were isolated and grown in culture and holds for animal studies. Thus, giving female rats 200 mg chemical hypoxia was induced by the addition of 1.5 mM melatonin per kg body weight (the equivalent of an KCN and 20 mM deoxyglucose to the superfusion fluid.
average-weight human consuming 14 g melatonin daily) Cells were preloaded with either tetramethylrhodamine throughout pregnancy caused no maternal or fetal toxicity (TMRM) in combination with either dichlorodihydrofl- [51] . uorescein (DCDHF), dihydrorhodamine 123 (DHR) or fluo 3 to determine the effects of melatonin, using confocal laser scanning microscopy, on H O levels, ROS con-3 . Mechanisms of melatonin's protective actions in 2 2 21 centrations and Ca levels, respectively. Chemical hypothe heart xia caused marked morphological changes of the cardiomyocytes and significantly increased H O , ROS and It is well accepted that O -derived reactants can cause 2 2 2 21
[Ca ] accumulation. Melatonin, at a concentration of contractile dysfunction of the myocardium and certainly i either 50 or 100 mM, significantly reduced these changes reperfusion of the heart with oxygenated blood after a (except for DCDHF fluorescence). These findings, as with period of ischemia causes oxidative damage in the rethe in vivo results summarized above, strongly implicate perfused tissue [52] . These toxic O -based reactants along 2 the antioxidant properties of melatonin in its protective with RNS (Fig. 3) are widely believed to play a significant effects against hypoxia / reoxygenation injury at the level of role in cardiopathophysiology after I / R [9, 10] . ?OH, hydroxyl radical; O , superoxide anion radical; MPO, myloperoxidase activity; [Ca ] , intracellular calcium levels.
i
a In these reports, previously pinealectomized rats exhibited greater cardiac malfunction and damage as a result of I / R injury; these results suggest that physiological (endogenous) levels of melatonin protect the heart during I / R.
b This is the only study on I / R and the potential of melatonin as a pharmacological protector that did not use the rat heart.
That melatonin directly detoxifies O -based free radicals acid (ONOOH) are likely involved in cardiomyocyte 2 and related reactants is well documented [53] [54] [55] [56] . For damage during I / R injury. Melatonin also has been shown example, melatonin is highly effective scavenger of the to neutralize these non-radical, but nevertheless toxic, ?OH as shown using a variety of techniques by many species [64, 65] [60] and N-acetyl-5-methoxIn I / R, NO? is generally considered to contribute to the ykynuramine (AFMK) [61, 62] , are also effective free resulting molecular damage, but under some other conradical scavengers [55, 56] . This cascade of reactions ditions inhibition of nitric oxide synthase may result in greatly increases the effective concentrations of melatonin detrimental effects. and may account, in part, for the high efficacy of this While melatonin's (and its metabolites) functions as a antioxidant in protecting against I / R injury at the level of free radical scavenger, including its ability to apparently the heart. Furthermore, the chief hepatic metabolite of directly detoxify H O [68] , may be important relative to 2 2 melatonin, namely, 6-hydroxymelatonin, is also reportedly its protective effects against injury due to hypoxia / reoxan effective free radial scavenger [63] . Thus, even when ygenation, it is unlikely that this is the sole means of its melatonin itself is metabolically converted to 6-hydroxybeneficial effects. Not specifically during cardiac I / R melatonin before it can function in the direct detoxification injury but in other cases of high oxidative stress, melatonin of a radical(s), its major hepatic metabolic product may be has been shown to promote the metabolism of O -based Thereafter, the two enzymes assigned the function of ( Fig. 1 ) [75] . Once at their target, these cells generate metabolizing H O , i.e. catalase and glutathione peroxiinflammatory mediators, e.g. leukotriene B , platelet-ac- 2 2 4 dase (GPx), and thereby reducing the formation of the tivating factor, etc., and they also lead to the activation of devastatingly toxic ?OH, have been shown to be stimulated oxidant-sensitive nuclear transcription factors, in particular by melatonin as well [70, 71] . These indirect antioxidative nuclear factor kappa B (NFkB); these agents, combined actions of melatonin could certainly magnify its protective with the generation of free radicals by the leukocytes, actions in the heart under conditions of high oxidative induce inflammatory mediators by endothelial cells and / or stress. Also of significance is a report by Urata et al. [72] mast cells which cause the mobilization of adhesion who have shown that melatonin increases the levels of molecules (selectins and ICAM). As a consequence, glutathione, an important intracellular antioxidant, by leukocytes adhere to the endothelium which leads to a stimulating its rate-limiting enzyme, gammacascade of events that contribute to cardiac damage. glutamylcysteine synthase.
Melatonin, due to its ability to reduce the expression of the Besides directly neutralizing and indirectly detoxifying adhesion molecules, P-selectin and ICAM [76] , as well as oxygen and nitrogen-based reactants, melatonin may also the suppression of NFkB translocation into the nucleus act at the level of the mitochondrial respiratory chain to [77] may be helpful in reducing cardiac injury during I / R. reduce electron leakage and, therefore, free radical geneAlthough the specific details of the mechanisms inration [73, 74] . While melatonin's actions at the level of the volved in the melatonin's ability to reduce oxidative mitochondria is a rather recent area of investigative damage at the level of the heart (and other tissues) during interest, the ability of the indole to reduce electron leakage hypoxia and especially during reperfusion remain to be is inferred from its stimulatory action on the activities of clarified, studies to date almost uniformly confirm the complex I and complex IV, its promotion of ATP probeneficial effects of the indole under these conditions. duction [73] , and its action in reducing oxidative damage Clearly, melatonin has at its disposal numerous means by to mitochondrial DNA. It is anticipated that research which it may limit cardiac damage during I / R (Table 2) , related to the mitochondrial actions of melatonin will but which of these functions plays the dominant role in its flourish in the next several years and the information protective actions is uncertain at this time. Beyond the garnered will clarify how the functions of melatonin at the actions of melatonin described, Duncker and Verdouw [27] mitochondrial level may be beneficial to the heart generalsummarize still other effects of melatonin which may be ly and during I / R injury specifically.
beneficial to cardiovascular physiology in general and Another important component of I / R injury is the cardiac function in particular. 
